CNBS
Amplify Seymour Cannabis ETF
Price Chart
Latest Quote
$26.22
| Previous Close | $25.75 |
| Open | $25.50 |
| Day High | $26.22 |
| Day Low | $25.50 |
| Volume | 4,375 |
Fund Information
| Net Assets | $84.07M |
| Expense Ratio | 0.76% |
| Category | Miscellaneous Sector |
| Fund Family | Amplify ETFs |
| Net Asset Value | $26.37 |
| Premium/Discount | -0.57% |
| P/E Ratio | 19.69 |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $27.22 |
| SMA50 | $28.14 |
| SMA200 | $26.58 |
| RSI | 42.97 |
| ATR | 0.8911 |
| Rel Volume | 0.99 |
Performance History
| Week | -1.09% |
| Month | -7.20% |
| Quarter | +9.12% |
| 6 Months | -12.12% |
| YTD | -9.42% |
| Year | +62.41% |
| 3 Years | -20.01% |
| 5 Years | -87.08% |
| 10 Years | -86.63% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $26.22 | 4,400 |
| 2026-07-16 | $25.75 | 1,900 |
| 2026-07-15 | $26.45 | 1,300 |
| 2026-07-14 | $27.32 | 1,900 |
| 2026-07-13 | $27.46 | 1,700 |
| 2026-07-10 | $26.51 | 1,600 |
| 2026-07-09 | $26.42 | 2,300 |
| 2026-07-08 | $27.25 | 1,800 |
| 2026-07-07 | $26.67 | 3,400 |
| 2026-07-06 | $26.65 | 12,900 |
| 2026-07-02 | $28.78 | 4,500 |
| 2026-07-01 | $28.24 | 9,000 |
| 2026-06-30 | $29.21 | 1,600 |
| 2026-06-29 | $27.97 | 1,800 |
| 2026-06-26 | $27.61 | 8,600 |
| 2026-06-25 | $27.17 | 5,300 |
| 2026-06-24 | $26.02 | 3,800 |
| 2026-06-23 | $26.36 | 2,400 |
| 2026-06-22 | $27.29 | 14,400 |
| 2026-06-18 | $29.03 | 3,900 |
About Amplify Seymour Cannabis ETF
Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund’s investment adviser, Amplify Investments LL. Pursuant to this strategy, it will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.
📰 Latest News
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
Zacks • 2026-05-14T17:06:00Z
New Executive Orders Boost Weed and Psilocybin ETFs
The Daily Upside • 2026-04-27T04:01:00Z
After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS
24/7 Wall St. • 2026-01-02T16:28:55Z
Cannabis ETF (CNBS) Hits New 52-Week High
Zacks • 2025-12-18T15:16:00Z
6 Top-Performing ETF Areas of Last Week
Zacks • 2025-12-17T12:00:00Z
5 Best-Performing Leveraged ETFs of Last Week
Zacks • 2025-12-15T14:00:00Z
Cannabis ETFs Soar Double-Digits on Friday: Here's Why
Zacks • 2025-12-15T11:00:00Z
The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO
Zacks • 2025-10-07T13:29:00Z
From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects
Zacks • 2025-10-06T17:11:00Z
Top-Performing ETF Areas of August That Are Up At Least 20%
Zacks • 2025-09-01T12:00:00Z